Statistics for Reviva Pharmaceuticals Holdings, (id:5581 RVPH)

Valuation metrics

Market cap

41.47M

Enterprise value

27.57M

Trailing P/E (ttm)

-0.69

Forward P/E

-1.53

PEG ratio

-1.53

Price/Sales (ttm)

Price/Book (mrq)

6.05

Enterprise Value/Revenue

Enterprise Value/EBITDA

-0.70

Overview

Shares outstanding

33.44M

Float

26.65M

Shares short

5.30M

% Held by insiders

0.15%

% Held by institutions

0.30%

Average volume (10 days)

1.01M

Average volume (90 days)

Price summary

52-Week low

0.60

52-Week high

5.67

52-Week change

-300.00%

Beta

-0.06

50-Day moving average

1.21

200-Day moving average

1.97

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

0.00%

Operating margin

0.00%

Operational effectiveness

Return on assets

-233.95%

Return on equity

-686.53%

Income statement

Revenue (ttm)

0.00

Revenue per share (ttm)

0.00

Quarterly revenue growth (yoy)

Gross profit (ttm)

0.00

EBITDA

0.00

Net income to common (ttm)

-35,994,728.00

Diluted EPS (ttm)

-1.08

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

6.18M

Total cash per share (mrq)

0.21

Total debt (mrq)

207.50K

Total Debt/Equity (mrq)

-0.02

Current ratio (mrq)

51.90%

Book value per share (mrq)

0.20

Cash flow

Cash flow statement

-35,257,728.00

Levered free cash flow (LFCF)

-17,416,516.00